Together these data confirm that circulating FSHD biomarkers reflect muscle pathogenesis, and suggest inflammatory S100A8/TLR4 signaling plays a role in pediatric-onset FSHD as well. The gene discussed is S100A8; the disease is facioscapulohumeral muscular dystrophy.